图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
肿瘤形成评论综述™
SJR: 0.631 SNIP: 0.503 CiteScore™: 2

ISSN 打印: 0893-9675
ISSN 在线: 2162-6448

肿瘤形成评论综述™

DOI: 10.1615/CritRevOncog.2014011844
pages 363-382

Tracking Down the Origin of Cancer: Metabolic Reprogramming as a Driver of Stemness and Tumorigenesis

Carlos Sebastian
Massachusetts General Hospital Cancer Center, Harvard Medical School, Cambridge Street, Simches Building, 4th floor, Boston, MA 02114

ABSTRACT

Metabolic reprogramming has recently emerged as a fundamental trait of cancer cells. Initially thought to be a consequence of rapid cell proliferation, recent data have reset this idea by demonstrating that metabolic reprogramming can actually drive tumorigenesis. The cancer stem cell (CSC) theory predicts that only a small subpopulation of cancer cells with stem cell properties, which derive from the cancer cell of origin, possesses tumor-initiating potential. However, whether metabolic reprogramming drives tumor formation by regulating the genesis of CSCs is not known. Importantly, the metabolic properties of stem cells and cancer cells are strikingly similar, and metabolic reprogramming is a key factor controlling stemness in these cells. This article reviews the current understanding of cancer metabolism and how it mirrors the metabolic requirements of stem cells. These two concepts are integrated and data demonstrating that metabolic reprogramming regulates CSCs function are discussed, suggesting that metabolic regulation of stemness could be at the origin of cancer.


Articles with similar content:

The Transcription Regulator Kruppel-Like Factor 4 and Its Dual Roles of Oncogene in Glioblastoma and Tumor Suppressor in Neuroblastoma
Forum on Immunopathological Diseases and Therapeutics, Vol.7, 2016, issue 1-2
Swapan K. Ray
Aberrant Regulation of Alternative Pre-mRNA Splicing in Hepatocellular Carcinoma
Critical Reviews™ in Eukaryotic Gene Expression, Vol.24, 2014, issue 2
Shuixiang Xie, Fan Zhu, Lijuan Liu, Chuanjie Zhang
Evolving Views of Breast Cancer Stem Cells and Their Differentiation States
Critical Reviews™ in Oncogenesis, Vol.19, 2014, issue 5
Ittai Ben-Porath, Reba Condiotti, Wenjun Guo
An Updated Review of Oral Cancer Stem Cells and Their Stemness Regulation
Critical Reviews™ in Oncogenesis, Vol.23, 2018, issue 3-4
Reuben H. Kim, Ki-Hyuk Shin
Kruppel-Like Factor 4: From Physiological Functions to Tumor Therapy
Forum on Immunopathological Diseases and Therapeutics, Vol.7, 2016, issue 1-2
Peng Li, Ruocong Zhao, Yunxin Lai